Chemotherapy-Induced Emesis in Elderly Cancer Patients: The Role of 5-HT₃-Receptor Antagonists in the First 24 Hours

Publisher： Karger

E-ISSN： 1423-0003|51|5|287-296

ISSN： 0304-324x

Source： Gerontology, Vol.51, Iss.5, 2005-08, pp. : 287-296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aprepitant as Salvage Therapy in Patients with Chemotherapy-Induced Nausea and Emesis Refractory to Prophylaxis with 5-HT₃ Antagonists and Dexamethasone

Oncology Research and Treatment, Vol. 29, Iss. 12, 2006-12 ,pp. : 557-561

Karger

Access to resources Recommend Favorite

Chemotherapy-induced nausea and vomiting and antiemetic prophylaxis with palonosetron versus other 5-HT₃receptor antagonists in patients with cancer treated with low emetogenic chemotherapy in a hospital outpatient setting in the United States

By Schwartzberg Lee Morrow Gary Balu Sanjeev Craver Chris Gayle Julie Cox David

Current Medical Research and Opinion, Vol. 27, Iss. 8, 2011-08 ,pp. : 1613-1622

Informa Healthcare

Access to resources Recommend Favorite

QoL evaluation of olanzapine for chemotherapy‐induced nausea and vomiting comparing with 5‐HT3 receptor antagonist

EUROPEAN JOURNAL OF CANCER CARE (ELECTRONIC), Vol. 24, Iss. 3, 2015-05 ,pp. : 436-443

John Wiley & Sons Inc

Access to resources Recommend Favorite

5-HT₃-Receptor Antagonists in the Management of Nausea and Vomiting in Cancer and Cancer Treatment

Oncology, Vol. 69, Iss. 2, 2005-09 ,pp. : 97-109

Karger

Access to resources Recommend Favorite

Role of Psychosocial Variables on Chemotherapy-Induced Nausea and Vomiting and Health-Related Quality of Life among Cancer Patients: A European Study

Psychotherapy and Psychosomatics, Vol. 84, Iss. 6, 2015-0 ,pp. : 339-347

Karger

Access to resources Recommend Favorite